Preliminary results of a European multicentre phase 1 study with Oncofid-PB for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder at the end of 12 consecutive weeks intensive course and during ongoing monthly maintenance phase
Abstract
Publication Date:
2020
Iris type:
1.5 Abstract in rivista
List of contributors:
Hurle, R; Guazzoni, G; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Carlos, L; Duran-Merino, R; Lazzeri, M
Published in: